​​​​​​​PEG-BIO Biopharm Co.,Ltd(chongqing).
News Center
Home >> 行业动态 >> Three years of pharmaceutical reform, five major changes, affecting all pharmaceutical companies
Three years of pharmaceutical reform, five major changes, affecting all pharmaceutical companies
Source:赛柏蓝 | Author:赛柏蓝 | Published time: 2018-08-20 | 1366 Views | Share:


3. China's new drug r&d results have been recognized by international peers

4. New drug development in China is recognized by the securities market

5.China engaged in new drug research and development companies in the global ratio from 4% in 2016 to 5% in 2017 in April, the formal implementation of the new Hong Kong stock exchange listing rules, allowing no revenues and profits are still in the stage of r&d biotech login of the securities market, this is a high recognition of Chinese medicine research and development achievements, at present, the existing pharmaceutical research and development enterprises ge li, paekche shenzhou successful listing, such as type and HuaLing medicine, cinda several research and development company is an IPO.

6.China's investment in pharmaceutical r&d is growing at the fastest rate in the world